The Prima photovoltaic retinal stimulation microchip, a brain-computer interface device designed to restore vision in patients with geographic atrophy, has launched commercially across 30 European countries.
July 24, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
A retina chip that restores sight goes on sale in Europe
Groundbreaking Retina Chip Designed to Restore Sight to Go on Sale in Europe
Vision-restoring chip gains EU approval
‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027
Science Corporation's vision-restoring chip receives EU approval
A new brain-computer implant is helping blind seniors see again, and it just got approved in Europe
US firm launches vision-restoring implant with EU approval
Science Corporation's vision-restoring chip wins EU approval | TechCrunch
Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related Macular Degeneration, a Leading Cause of Blindness
L'UE approva PRIMA: il chip fotovoltaico sottoretinico per i pazienti con atrofia geografica
